Spontaneous lymphoblastoid cell lines from patients with Epstein-Barr virus infection show highly variable proliferation characteristics that correlate with the expression levels of viral microRNAs
Open Access
- 30 September 2019
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 14 (9) , e0222847
Abstract
The Epstein-Barr virus (EBV) induces B-cell proliferation with high efficiency through expression of latent proteins and microRNAs. This process takes place in vivo soon after infection, presumably to expand the virus reservoir, but can also induce pathologies, e.g. an infectious mononucleosis (IM) syndrome after primary infection or a B-cell lymphoproliferation in immunosuppressed individuals. In this paper, we investigated the growth characteristics of EBV-infected B-cells isolated from transplant recipients or patients with IM. We found that these cells grew and withstood apoptosis at highly variable rates, suggesting that the expansion rate of the infected B-cells widely varies between individuals, thereby influencing the size of the B-cell reservoir and the ability to form tumors in infected individuals. All viruses investigated were type 1 and genetically close to western strains. EBV-infected B-cells expressed the transforming EBV latent genes and microRNAs (miRNAs) at variable levels. We found that the B-cell growth rates positively correlated with the BHRF1 miRNA levels. Comparative studies showed that infected B-cells derived from transplant recipients with iEBVL on average expressed higher levels of EBV miR-BHRF1 miRNAs and grew more rapidly than B-cells from IM patients, suggesting infection by more transforming viruses. Altogether, these findings suggest that EBV infection has a highly variable impact on the B-cell compartment that probably reflects the genetic diversity of both the virus and the host. It also demonstrates the unexpected finding that B-cells from different individuals can grow at different speed under the influence of the same virus infection.Keywords
Funding Information
- DZIF (clinical leave stipend)
- Hexal AG (travel grant)
- Octapham (travel grant)
- Sanofi-Aventis (honoraria)
This publication has 37 references indexed in Scilit:
- The Members of an Epstein-Barr Virus MicroRNA Cluster Cooperate To Transform B LymphocytesJournal of Virology, 2011
- A Viral microRNA Cluster Strongly Potentiates the Transforming Properties of a Human HerpesvirusPLOS Pathogens, 2011
- Micro RNAs of Epstein-Barr Virus Promote Cell Cycle Progression and Prevent Apoptosis of Primary Human B CellsPLOS Pathogens, 2010
- The microRNAs of Epstein–Barr Virus are expressed at dramatically differing levels among cell linesVirology, 2009
- Comprehensive Profiling of Epstein-Barr Virus MicroRNAs in Nasopharyngeal CarcinomaJournal of Virology, 2009
- LMP1 Strain Variants: Biological and Molecular PropertiesJournal of Virology, 2006
- Epstein–Barr Virus MicroRNAs Are Evolutionarily Conserved and Differentially ExpressedPLOS Pathogens, 2006
- Epstein–Barr virus-induced B-cell transformation: quantitating events from virus binding to cell outgrowthJournal of General Virology, 2005
- Ionomycin-activated Calpain Triggers ApoptosisJournal of Biological Chemistry, 2002
- CYTOLOGY OF BURKITT'S TUMOUR (AFRICAN LYMPHOMA)The Lancet, 1964